Folks with early untreated Parkinson's disease with low vitamin B12 (less than 157 pmol/L) were found to have greater worsening of mobility and cognitive decline over time.
Further, elevated homocysteine predicted greater cognitive decline.
Mov Disord. 2018 Mar 6
Showing posts with label PD. Show all posts
Showing posts with label PD. Show all posts
Monday, August 13, 2018
Saturday, September 2, 2017
Reduce Parkinson's Disease Risk: Truncal Vagotomy ?
Researchers out of Sweden reviewed patients that underwent truncal vagotomy (a surgical procedure that functionally disconnects multiple abdominal organs by cutting the vagus nerve supply to them) and found a decreased risk of developing Parkinson's disease compared to controls. In fact there was a greater decreased risk in those that underwent selective vagotomy (which disconnects only the stomach).
These findings offer further support for the Braak hypothesis that Parkinson's disease starts in the gut and spreads to the brain.
Neurology 2017Apr 26
These findings offer further support for the Braak hypothesis that Parkinson's disease starts in the gut and spreads to the brain.
Neurology 2017Apr 26
Friday, September 1, 2017
Is Parkinson's Disease an Autoimmune Disease?
Following up an earlier study, researchers at Columbia and La Jolla have discovered a population of T cells in the blood of patients with Parkinson's disease that recognize alpha-synuclein peptides providing evidence that PD may be,in part,an autoimmune disease, and autoimmune targeted treatment could potentially slow or stop the disease process.
Nature 2017;Epub 2017 Jun21
Nat Commun 2014;5:3633
Nature 2017;Epub 2017 Jun21
Nat Commun 2014;5:3633
Monday, December 28, 2015
Phenylbutyrate : A Promising Treatment for Parkinson's Disease
University of Colorado School of Medicine researchers have found that phenylbutyrate stops the progression of PD in mice. The drug, previously approved for treatment of a rare metabolic disease in infants, has been found to increase alpha-synuclein in the bloodstream of both patients with early PD and age matched controls. Alpha-synuclein accumulates in excess in the brain's of patients with PD. Therefore, the finding of an increase in alpha-synuclein in the blood of phenylbutyrate treated patients with PD suggests that this protein that accumulates in excess in their brain's is being cleared by the drug. This new research follows the earlier study of Zhou as published in 2011.
http://bit.ly/NT-SfN-phenylbutyrate
J Biol Chem 2011;286:1491-1451
http://bit.ly/NT-SfN-phenylbutyrate
J Biol Chem 2011;286:1491-1451
Friday, July 19, 2013
Eat Your Nicotine Containing Veggies and Decrease Parkinson's Risk
In a population based study of 490 newly diagnosed patients with Parkinson's disease and 644 healthy controls, patients that consumed fruits and vegetables that contain nicotine ie. from the same botanical family as tobacco, Solanaceae, including peppers (especially peppers), tomatoes and potatoes.
Annals of Neurology May 9, 2013
Annals of Neurology May 9, 2013
Non-melanoma Skin Cancer Decreases Risk of Alzheimer's
Those older than 70 years that develop non-melanoma skin cancer have a dramatically decreased risk of Alzheimer's disease in a study of 1,102 patients.
Neurology May 15, 2013
Conversely, it is known that patients with Parkinson's disease have a higher-than-expected frequency of melanoma and patients with melanoma are more likely to develop PD.
Int J Cancer. 2011 May 15; 128(10):2251-60
Neurology May 15, 2013
Conversely, it is known that patients with Parkinson's disease have a higher-than-expected frequency of melanoma and patients with melanoma are more likely to develop PD.
Int J Cancer. 2011 May 15; 128(10):2251-60
Saturday, November 24, 2012
Intranasal Stem cell Delivery in PD Rat model
Mesenchymal stem cells (MSC) were delivered into the nose preferentially migrated to the brain and survived up to six months improving motor function significantly (up 68%) in the rat model of Parkinson's disease. Levels of dopamine were much higher in the treated rats.
Rejuvenation Research Volume: 14 Issue 1: February 17, 2011
Rejuvenation Research Volume: 14 Issue 1: February 17, 2011
Labels:
PD,
Stem cell treatment of Parkinson's
Subscribe to:
Posts (Atom)